Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport + Physical Therapy for Spastic CP
NCT03704155Completed
- Sponsor
- University of Nove de Julho
- Start
- Jan 2017
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of botulinum toxin type A in cerebral palsy (CP) (2 arms), sponsored by University of Nove de Julho. Primary endpoints: Severity of muscle hypertonia at 3 months and Functional balance at 3 months. Started Jan 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03704155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03704155.